An Anoikis-Based Prognostic Signature Identifies MYC as a Key Regulator of Malignancy and Immunotherapy Resistance in Bladder Cancer
This work demonstrated significant prognostic value for the ARG-based model. Specific ARGs could function as crucial biomarkers for patient outcome, while simultaneously offering new avenues for therapeutic intervention.
Authors
- Yuefeng Kong (ORCID: https://orcid.org/0009-0005-1921-9867)
- Siping Zeng (ORCID: https://orcid.org/0009-0008-6045-3518)
- Haisong Lin (ORCID: https://orcid.org/0000-0001-6669-4592)
- Suchun Wei (ORCID: https://orcid.org/0000-0001-9652-7859)
- Yi Zhan (ORCID: https://orcid.org/0009-0003-7045-2563)
- Jiao Peng (ORCID: https://orcid.org/0009-0004-0757-2922)
- Zhen Tang (ORCID: https://orcid.org/0009-0007-5303-8853)
- Xiaoyu Pan (ORCID: https://orcid.org/0009-0001-4349-4771)
Institutions
- First Affiliated Hospital of GuangXi Medical University (CN)
- Fourth Affiliated Hospital of Guangxi Medical University (CN)
- Center for Genomic Science (IT)
Publication Details
- Journal
- Frontiers in Bioscience-Landmark
- Published
- 2025-10-28
- DOI
- https://doi.org/10.31083/fbl45386
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00